Part of the debate – in Westminster Hall at 10:31 am on 24 June 2015.
It is a great pleasure to serve under your chairmanship, Mr Owen, and it is a particular pleasure to respond to this debate, secured by Paul Blomfield. I have heard much about his inspiring leadership in the higher education sector.
I start by making a declaration of interest. I am still an honorary professor at the University of Stirling, and in recent times I have undertaken a number of ethical reviews of research proposals into matters such as tobacco. One great strength of UK universities that has not been mentioned in this debate is their approach to ethical research, of which universities throughout the UK can be tremendously proud. Our universities’ strength of ambition to conduct high-quality, leading ethical research is increasingly becoming a selling point. In a few days’ time I will give advice at the request of the University of Dundee and the University of St Andrews, for which I will be paid the princely sum of nothing—I think that is a fair reflection of the quality of my comments to come.
In another context—it is not exactly a declaration of interest—I wanted to say this at some stage in my parliamentary career and now is an appropriate time. My late brother, Jim, who died not all that long ago, graduated from Glasgow University before emigrating to Canada. He became a leading scientist and, after a number of years, was chairman of the OECD science and technology committee. I hope he would be pleased that I am speaking in this debate.
Scotland has a remarkable tradition in higher education and research. Even today, 77% of all research by Scottish universities submitted to the research excellence framework is classified as “world-leading” or “internationally excellent,” which is ahead of the UK average. Some 86% of Scottish research is judged as being “outstanding” or having “very considerable” impact, which compares with the UK average of 83.9%. Sammy Wilson talked about impact brilliantly in his three minutes and 57 seconds.
Scottish universities also excel, and have a great tradition, in science. Hon. Members gave many examples from their constituencies, but I will give just one example not from my constituency but from Glasgow University, which ties into the importance of considering these matters not merely in the context of a constituency, of Scotland or of the UK but internationally, too. South Glasgow University Hospital, as well as catering for more than 1,000 patients, hosts a campus of Glasgow University and its world-leading Stratified Medicine Scotland innovation centre, a state-of-the-art clinical research facility for clinical trials. The hospital will also be the future site of the university’s Europe-leading imaging centre of excellence. A number of hon. Members have pointed out the fundamental importance of European connections to our universities. I would say that it goes beyond Europe: our global connections in the UK, and in Scotland, are of fundamental importance and are to be treasured.
Scotland’s universities are proud of their Scottish roots, but they are equally proud of being outward-looking and highly collaborative within the UK, within Europe and internationally. What might be described as the best of our universities are in a worldwide research ecosystem. Such interchange is important to everyone. Engagement is important to Scottish universities, and they also have something to offer when they engage with others.
In practical terms, we want to see the continuation of the dual support system for research funding in the UK. We want to see more UK-wide and Europe-wide collaboration that underpins excellence in research. Some hon. Members talked about the value of localised competition in small places such as London but, looking more widely, I am pretty sure that many London universities benefit from how they relate with universities in, for example, California, South Africa, Germany and many other parts of the world. The same is true for Scotland and every constituency with a university.
I am slightly surprised that nobody has made significant mention of the Nurse review of UK research councils. The consultation phase closed in April, and Sir Paul Nurse is now considering the evidence. I am pleased to say that the Scottish Government have already arranged to have further consultations with Sir Paul in the coming weeks, as has Universities Scotland. From that review we hope to develop more imaginative approaches to research funding that recognise, for example, the connection to innovation, which others have talked about so eloquently in this debate.
On European research partnerships, the hon. Member for Sheffield Central mentioned the importance of the seventh framework programme for research. It indicates the importance of that European connection to Scottish universities that, by the time the programme ended in 2013, Scotland had been awarded €636 million in funding. Scotland has received 11.2% of the UK’s European Research Council funding, which is well above our population share. For Scottish universities it is fundamentally important that we have strong and continuing links with the European Union, as well as with others across the globe.
I will conclude with a couple of questions for the Minister, one of which I have not mentioned thus far. The immigration policy pursued by this Government is a barrier to attracting leading research talent from across the world, as some Opposition Members have already mentioned. That is critical. We are particularly concerned in Scotland, and we call for the return of the post-study work visa to enable people who are here to study for higher research-end degrees to continue contributing. It is completely and utterly insane that the Government are discriminating against such people when they have so much to contribute to this country. We ask the Government, in the coming Budget, to address the fears of some of our universities about what may occur. They fear that there will be a squeeze on research funding at a time when, as many Opposition Members have said, we need increased investment in R and D for the benefit of productivity and innovation.